Skip to main content

Volume 18 - Issue 1 - January, 2006

Editorial Message
08/01/2008
Richard E. Shaw, PhD, FACC
Dear Readers, This issue of the Journal of Invasive Cardiology commences our 18th year of publication. There has been incredible growth in the field of invasive cardiology during 2005. Many of these growth areas have challenged the...
Dear Readers, This issue of the Journal of Invasive Cardiology commences our 18th year of publication. There has been incredible growth in the field of invasive cardiology during 2005. Many of these growth areas have challenged the...
Dear Readers, This issue of the...
08/01/2008
Journal of Invasive Cardiology
Case Report
08/01/2008
Thomas A. Hennebry, MB, BCh, BAO, MD; Abdul Rashid, MD; Jorge Saucedo, MD
Case Report. A 57-year-old woman underwent orthotopic cardiac transplant in 1997 secondary to nonischemic cardiomyopathy. Her symptoms of heart failure started in 1993 after a week of flu-like illness. A year later, she was diagnosed with...
Case Report. A 57-year-old woman underwent orthotopic cardiac transplant in 1997 secondary to nonischemic cardiomyopathy. Her symptoms of heart failure started in 1993 after a week of flu-like illness. A year later, she was diagnosed with...
Case Report. A 57-year-old woman...
08/01/2008
Journal of Invasive Cardiology
Case Report
08/01/2008
David Zemanek, MD, PhD; Josef Veselka, MD, PhD, FESC, FSCAI
Aneurysms of the ascending aorta are not uncommon in the catheterization laboratory. When encountered, they lead to problems catheterizing the left coronary artery in particular. We typically use catheters with a large bend in these cases...
Aneurysms of the ascending aorta are not uncommon in the catheterization laboratory. When encountered, they lead to problems catheterizing the left coronary artery in particular. We typically use catheters with a large bend in these cases...
Aneurysms of the ascending aorta...
08/01/2008
Journal of Invasive Cardiology
Case Report
08/01/2008
Alan Zajarias, MD; Srihari Thanigaraj, MD; Megumi Taniuchi, MD, PhD
Non-penetrating thoracic trauma has been associated with multiple structural and electrical cardiac injuries and complications with a mortality rate of up to 15%.1 The mechanisms for non-penetrating cardiac injury include: direct trauma,...
Non-penetrating thoracic trauma has been associated with multiple structural and electrical cardiac injuries and complications with a mortality rate of up to 15%.1 The mechanisms for non-penetrating cardiac injury include: direct trauma,...
Non-penetrating thoracic trauma...
08/01/2008
Journal of Invasive Cardiology
Case Report
08/01/2008
S. Anandaraja, MD, DM; Kewal Krishan Talwar, MD, DM; Nitish Naik, MD
Percutaneous coronary interventions (PCI) are uncommon causes of coronary artery aneurysms (CAA). The incidence of CAA after percutaneous transluminal coronary angioplasty (PTCA) ranges from 3.9–5%,1,2,5–7 and after directional coronary...
Percutaneous coronary interventions (PCI) are uncommon causes of coronary artery aneurysms (CAA). The incidence of CAA after percutaneous transluminal coronary angioplasty (PTCA) ranges from 3.9–5%,1,2,5–7 and after directional coronary...
Percutaneous coronary...
08/01/2008
Journal of Invasive Cardiology
IAGS (International Andreas Gruentzig Society) Proceedings
08/01/2008
Michael L. Marin, MD; Eberhard Zeitler, MD; Klemens Barth, MD; Michael Lawrence-Brown, MD; Ernst Schneider, MD; Wolfgang Ritter, MD; Andrew Cragg, MD; Douglas M. Cavaye, MD
Wolfgang Ritter: We know that all devices have problems; for example, the VanGuard or the AneuRx® (Medtonic, Inc., Sunnyvale, California) can incur some disintegration 4 to 5 years postimplantation. With the Zenith device, the problem of late...
Wolfgang Ritter: We know that all devices have problems; for example, the VanGuard or the AneuRx® (Medtonic, Inc., Sunnyvale, California) can incur some disintegration 4 to 5 years postimplantation. With the Zenith device, the problem of late...
Wolfgang Ritter: We know that...
08/01/2008
Journal of Invasive Cardiology
IAGS (International Andreas Gruentzig Society) Proceedings
08/01/2008
Scott Byrd; Philip Reid; John David Spencer, MD; Renato DeRita, MS; Mike Cowley, MD
Philip Reid (Eli Lilly & Company): Speaking as a cardiologist, not as a neurologist, I find that the challenge with the trial that Renato has just described is to demonstrate the efficacy of abciximab in acute nonhemorrhagic stroke patients....
Philip Reid (Eli Lilly & Company): Speaking as a cardiologist, not as a neurologist, I find that the challenge with the trial that Renato has just described is to demonstrate the efficacy of abciximab in acute nonhemorrhagic stroke patients....
Philip Reid (Eli Lilly &...
08/01/2008
Journal of Invasive Cardiology
08/01/2008
Javier Escaned, MD, PhD; Sergio Villarreal, MD; Maria-Jose Perez-Vizcayno, MD; Cesar Conde, MD; Fernando Alfonso, MD, PhD, FESC; Camino Bañuelos, MD; Dominick J. Angiolillo, MD, PhD; Antonio Fernandez-Ortiz, MD, PhD; Carlos Macaya, MD, PhD; Rosana Hernandez-Antolin, MD, PhD; Raúl Moreno-Gómez, MD, PhD
Primary percutaneous coronary intervention (PCI) is the best reperfusion strategy in patients with ST-elevation acute myocardial infarction (AMI).1 This is mainly because it achieves a very high rate of successful recanalization of the...
Primary percutaneous coronary intervention (PCI) is the best reperfusion strategy in patients with ST-elevation acute myocardial infarction (AMI).1 This is mainly because it achieves a very high rate of successful recanalization of the...
Primary percutaneous coronary...
08/01/2008
Journal of Invasive Cardiology
08/01/2008
Alexandre S. Quadros, MD, PhD; Rogério Sarmento-Leite, MD, PhD; Carlos A.M. Gottschall, MD, PhD, FSCAI, FIAGS
Drug-eluting stents (DES) significantly decrease the need for a new target vessel revascularization (TVR) after coronary intervention,1–4 but its widespread use is still limited by cost issues.5,6 DES are currently used in more than 70% of...
Drug-eluting stents (DES) significantly decrease the need for a new target vessel revascularization (TVR) after coronary intervention,1–4 but its widespread use is still limited by cost issues.5,6 DES are currently used in more than 70% of...
Drug-eluting stents (DES)...
08/01/2008
Journal of Invasive Cardiology
Commentary
08/01/2008
Douglas W. Losordo, MD; Frederick G.P. Welt, MD
Nearly two years after the widespread introduction of drug-eluting stents (DES) on the U.S. market, it is perhaps time to step back and evaluate the impact of this revolutionary technology on the practice of cardiology. Financial modeling has...
Nearly two years after the widespread introduction of drug-eluting stents (DES) on the U.S. market, it is perhaps time to step back and evaluate the impact of this revolutionary technology on the practice of cardiology. Financial modeling has...
Nearly two years after the...
08/01/2008
Journal of Invasive Cardiology
08/01/2008
Ian T. Meredith, BSc, PhD, MBBS, FRACP, MD; H.M. Omar Farouque, MBBS, PhD, MD; James D. Cameron, MBBS, MD, BE(Elec), MEngSci; Stephen G. Worthley, MBBS, PhD, MD, PhDH, MB, BS 
The development and even progression of coronary atherosclerotic lesions may occur without compromising the lumen in the early phases due to outward growth of the vessel wall; a concept known as “positive” or “outward” arterial remodeling.1...
The development and even progression of coronary atherosclerotic lesions may occur without compromising the lumen in the early phases due to outward growth of the vessel wall; a concept known as “positive” or “outward” arterial remodeling.1...
The development and even...
08/01/2008
Journal of Invasive Cardiology
08/01/2008
Edo Kaluski, MD; Alberto Hendler, MD; Avi Aronovich, MD; Izhak Zyssman, MD; Yosef Gurevich, MD; Alex Blatt, MD; Meir Reicher, MD; Marina Leitman, MD; Istvan Czuriga, MD; Zvi Vered, MD; Ricardo Krakover, MD
Primary angioplasty has become the preferred therapeutic modality in patients with acute myocardial infarction (AMI). Despite a rapid and sustained restoration of flow through a previously occluded epicardial coronary artery, perfusion at the...
Primary angioplasty has become the preferred therapeutic modality in patients with acute myocardial infarction (AMI). Despite a rapid and sustained restoration of flow through a previously occluded epicardial coronary artery, perfusion at the...
Primary angioplasty has become...
08/01/2008
Journal of Invasive Cardiology
Clinical Images
08/01/2008
Cesar Moris, MD, PhD; Maria Martin, MD, PhD; Iñigo Lozano Martinez-Luengas, MD, PhD, FESC
The pigtail is the preferred catheter for left ventriculography. Because of its end-hole, which allows its manipulation with a guidewire, it can be advanced to the left ventricle both by the femoral and brachial approaches. The design of the...
The pigtail is the preferred catheter for left ventriculography. Because of its end-hole, which allows its manipulation with a guidewire, it can be advanced to the left ventricle both by the femoral and brachial approaches. The design of the...
The pigtail is the preferred...
08/01/2008
Journal of Invasive Cardiology
Case Report
08/01/2008
Anand R. Shenoy, MD, DM; P. Padmakumar, MD, DM; V. Subashchandra, MD, DM, FRCP
Case Report. A 6-month-old child was admitted with cyanosis noted from birth with failure to thrive, cyanotic spells and worsening cyanosis. The child weighed 4.5 kg, had severe systemic desaturation (
Case Report. A 6-month-old child was admitted with cyanosis noted from birth with failure to thrive, cyanotic spells and worsening cyanosis. The child weighed 4.5 kg, had severe systemic desaturation (
Case Report. A 6-month-old child...
08/01/2008
Journal of Invasive Cardiology
Case Report
08/01/2008
Paul T. Vaitkus, MD, MBA; Justin P. Levisay, MD
Stent embolization is a relatively rare but serious complication of coronary stenting. Early reports identified hand-crimped and coiled stents as being particularly prone to embolization.1 In addition, certain procedural and lesion...
Stent embolization is a relatively rare but serious complication of coronary stenting. Early reports identified hand-crimped and coiled stents as being particularly prone to embolization.1 In addition, certain procedural and lesion...
Stent embolization is a...
08/01/2008
Journal of Invasive Cardiology
08/01/2008
Mark H. Hoyer, MD
Current treatment strategies for patients with single ventricle physiology are aimed toward Fontan operations. Often, the Fontan completion is performed with an intentional fenestration to allow systemic venous decompression at the expense of...
Current treatment strategies for patients with single ventricle physiology are aimed toward Fontan operations. Often, the Fontan completion is performed with an intentional fenestration to allow systemic venous decompression at the expense of...
Current treatment strategies for...
08/01/2008
Journal of Invasive Cardiology
Rapid Communication
08/01/2008
Worawut Tassanawiwat, MD; Giuseppe G.L. Biondi-Zoccai, MD, PhD; Ioannis Iakovou, MD; John V. Cosgrave, MD; Nuccia Morici, MD; Giueseppe Massimo Sangiorgi, MD, PhD; Matteo Montorfano, MD; Antonio Colombo, MD
Drug-eluting stents (DES) have been established as a safe and effective tool in preventing in-stent restenosis and repeat revascularization in selected patients and lesions.1,2 However, individual and procedure-related factors can reduce...
Drug-eluting stents (DES) have been established as a safe and effective tool in preventing in-stent restenosis and repeat revascularization in selected patients and lesions.1,2 However, individual and procedure-related factors can reduce...
Drug-eluting stents (DES) have...
08/01/2008
Journal of Invasive Cardiology
Commentary
08/01/2008
John J. Young, MD
Peripheral arterial disease (PAD) is a problem of substantial public health importance. The disorder is estimated to affect 27 million people in Europe and North America alone.1 Recent data have consistently revealed a sharp increase in PAD...
Peripheral arterial disease (PAD) is a problem of substantial public health importance. The disorder is estimated to affect 27 million people in Europe and North America alone.1 Recent data have consistently revealed a sharp increase in PAD...
Peripheral arterial disease...
08/01/2008
Journal of Invasive Cardiology
Commentary
08/01/2008
David R. Ramsdale, FRCP, MD, BSc, MBChB; Shahid Aziz, BSc, MD, MRCP, MBChB
This short paper by Moreno et al. claims to show that patients with a chronic total occlusion (CTO) in a non-culprit coronary artery, who also have multivessel disease (MVD) and an acute myocardial infarction (MI) have a worse outcome than...
This short paper by Moreno et al. claims to show that patients with a chronic total occlusion (CTO) in a non-culprit coronary artery, who also have multivessel disease (MVD) and an acute myocardial infarction (MI) have a worse outcome than...
This short paper by Moreno et...
08/01/2008
Journal of Invasive Cardiology
08/01/2008
Vickie S. Takes, RT(R), CCRC, RN; Jon H. Lemke, PhD, MD; Matthew J. Kapalis, DO, BA, BSc, BS; Jon Robken, MD; H. Lester Kirchner, MD; Theresa Palabrica, MD; Eric J. Dippel, MD; Nicolas W. Shammas, MD, MS, FACC, FSCAI, FACP, FSVM
Balloon injury to the vessel wall triggers a reaction of thrombosis, inflammation and neointimal proliferation. The inflammatory process is mediated by a complex interaction between blood cells (platelets and leukocytes), coagulation factors...
Balloon injury to the vessel wall triggers a reaction of thrombosis, inflammation and neointimal proliferation. The inflammatory process is mediated by a complex interaction between blood cells (platelets and leukocytes), coagulation factors...
Balloon injury to the vessel...
08/01/2008
Journal of Invasive Cardiology